Pharma-Bio Serv, Inc. (PBSV) stock
PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
$0.48+0.08 (+20.00%)
Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –
Pharma-Bio Serv total assets
Total assets on the balance sheet at the end of each period.
Pharma-Bio Serv's total assets was $11.44M at Jul 31, 2026. For fiscal 2025 it was $13.65M, down 16.2% from the year before. Over ten years it grew -5.5% a year on average. The highest annual figure on record is $29.92M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $13.65M | -16.2% |
| FY2024 | Oct 31, 2024 | $16.29M | -18.1% |
| FY2023 | Oct 31, 2023 | $19.90M | -3.6% |
| FY2022 | Oct 31, 2022 | $20.65M | -13.7% |
| FY2021 | Oct 31, 2021 | $23.92M | -20.0% |
| FY2020 | Oct 31, 2020 | $29.92M | +12.3% |
| FY2019 | Oct 31, 2019 | $26.63M | +4.9% |
| FY2018 | Oct 31, 2018 | $25.38M | +13.5% |
| FY2017 | Oct 31, 2017 | $22.35M | -6.9% |
| FY2016 | Oct 31, 2016 | $24.00M | -0.6% |
| FY2015 | Oct 31, 2015 | $24.14M | +4.0% |
| FY2014 | Oct 31, 2014 | $23.21M | +9.1% |
| FY2013 | Oct 31, 2013 | $21.28M | +35.3% |
| FY2012 | Oct 31, 2012 | $15.74M | +45.0% |
| FY2011 | Oct 31, 2011 | $10.85M | +65.5% |
| FY2010 | Oct 31, 2010 | $6.56M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | $11.44M | -15.8% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $11.50M | -17.3% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $13.55M | -15.7% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $13.65M | -16.2% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $13.59M | -16.7% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $13.90M | -17.9% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $16.08M | -16.4% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $16.29M | -18.1% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | $16.32M | -19.6% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $16.92M | -13.7% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $19.23M | -8.0% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $19.90M | -3.6% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $20.30M | -0.2% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $19.62M | -2.7% |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | $20.90M | -12.6% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $20.65M | -27.8% |
| Q1 FY2022CQ4 2021 | Jul 31, 2022 | $20.33M | -27.1% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | $20.16M | -33.2% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $23.92M | -20.0% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $28.59M | -5.0% |
| Q2 FY2021CQ1 2021 | Apr 30, 2021 | $27.90M | -2.6% |
| Q1 FY2021CQ4 2020 | Jan 31, 2021 | $30.20M | +15.4% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $29.92M | +12.3% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $30.10M | +14.7% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $28.64M | +11.6% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $26.16M | +3.5% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $26.63M | +4.9% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $26.25M | +12.6% |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $25.65M | +14.0% |
| Q1 FY2019CQ4 2018 | Jan 31, 2019 | $25.28M | +12.8% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $25.38M | +13.5% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $23.31M | +3.5% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | $22.51M | -0.2% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $22.41M | -2.8% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $22.35M | -6.9% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | $22.51M | -6.3% |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | $22.56M | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | $23.06M | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | $24.00M | – |
| Q3 FY2016CQ2 2016 | Jul 31, 2016 | $24.02M | – |
See a number that looks wrong?